suspensie voor injectie 40 mg/ml
Sponsors
Janssen - Cilag International, Leiden University Medical Center, Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Medisch Spectrum Twente
Conditions
Geographic AtrophyMenière's diseaseRheumatoid arthritisRheumatoid arthritis according to 2010 criteria
Phase 2
A Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Active, not recruitingCTIS2022-500746-16-00
Start: 2023-08-11Target: 118Updated: 2025-12-15
Long-term Extension Study for Participants with Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) in JNJ-81201887 Parent Clinical Studies
RecruitingCTIS2022-500747-21-00
Start: 2025-02-27Target: 120Updated: 2025-08-25
Phase 3
Phase 4
PeRsonalIzed MEdicine in Rheumatoid Arthritis (PRIMERA trial): a multicenter, open-label, randomized controlled trial comparing usual care with a tailor-made approach
Not yet recruitingCTIS2024-511530-12-01
Target: 300Updated: 2024-10-01
Filgotinib bridging in newly diagnosed rheumatoid arthritis patients (FAST RA trial); A pragmatic randomized controlled non-inferiority low intervention clinical trial
Not yet recruitingCTIS2024-517112-30-00
Target: 168Updated: 2025-01-16